Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tops & Flops Stocks

Security Change (%) ▲ 1w 1m 1y YTD 3y 5y
Invitae Corp -78.840% - - - - - -
Iovance Biotherapeutics Inc. -12.280% 3.081% 1.642% 84.501% 58.555% -47.184% -
Bluebird Bio Inc. -11.030% 30.986% -4.888% -75.381% -11.793% -95.607% -
Agios Pharmaceuticals Inc. -3.110% 1.307% 13.139% 31.356% 50.485% -32.211% -31.507%
Acadia Pharmaceuticals -3.080% -6.564% -11.091% -25.939% -48.627% -15.786% -37.610%
Genomic Health -2.270% - - - - - -
Novocure Ltd -1.990% 14.297% 10.171% -76.039% 5.849% -90.449% -
Ultragenyx Pharmaceutical Inc. -1.540% -3.960% -16.738% -9.767% -11.009% -54.353% -35.740%
Emergent Biosolutions Inc. -1.270% 32.454% 90.764% -50.857% 82.630% -91.971% -90.394%
Arrowhead Pharmaceuticals Inc. -1.030% 4.220% -0.929% -36.181% -16.690% -57.017% 38.000%
Blueprint Medicines Corp -0.940% 1.354% 18.938% 103.730% 22.485% 30.758% -
Xencor Inc. -0.890% 20.856% 14.141% -8.130% 9.709% -35.244% -
Opko Health Inc. -0.880% -0.224% -9.837% -31.662% -18.695% -62.949% -38.274%
Repligen Corp. -0.810% -2.675% -9.931% 6.039% -9.905% -2.139% -
PTC Therapeutics Inc. -0.700% -8.387% 15.447% -43.762% 12.698% -14.458% -19.604%
Alnylam Pharmace. -0.180% 0.857% -1.706% -25.527% -20.226% 28.656% 128.110%
Mirati Therapeutics Inc. -0.040% - - - - - -
Exelixis Inc. 0.000% -2.667% -6.039% 14.489% -8.272% -2.762% 14.620%
Amicus Therapeutics Inc. 0.000% -7.895% -19.725% -17.453% -34.211% 9.375% -
Neurocrine Bioscience 0.080% -0.307% 1.445% 45.988% 8.885% 73.478% 82.700%
Catalent Inc. 0.340% 0.459% 0.114% 64.507% 27.573% -40.610% 26.957%
Charles River Labs Intl 0.550% -1.026% -10.389% 22.979% -0.376% -24.752% -
Sage Therapeutics Inc. 0.610% -5.608% -24.269% -75.151% -42.350% -80.719% -
United Therapeutics 1.010% 2.366% 13.016% 29.042% 24.388% 48.554% 195.294%
Spark Therapeutics 1.030% - - - - - -